Results 211 to 220 of about 249,445 (302)

Drug-resistant tuberculosis and pulmonary co-infections in immunocompromised patients: from multi-omics to precision therapy. [PDF]

Front Microbiol
Wang A, Reheman H, Chen X, Shang M, Abulikemu D, Wang H.   +5 more
europepmc   +1 more source

Trends and regional variation in antibiotic prescribing by dentists in Finland, 2012–2025: A register‐based study

European Journal of Oral Sciences, EarlyView.
Abstract This nationwide register‐based study aimed to investigate trends and regional variation in the number of antibiotic prescriptions issued by dentists in Finland from 2012 to 2025. Data on reimbursed outpatient antibiotic prescriptions dispensed by Finnish pharmacies were used.
Terhi Laitala, Emma Aarnio, Katariina Tuomilinna, Eero Raittio, Jukka Leinonen   +4 more
wiley   +1 more source

Severe Mpox-Associated Proctocolitis Mimicking Opportunistic Colitis in a Liver Transplant Recipient. [PDF]

ACG Case Rep J
Deepali F, Rembalsky A, Akinwuntan J, Jara-Tantoco MN, Bhatia K, Ezaz G.   +5 more
europepmc   +1 more source

Early de-escalation of antifungal treatment in critically ill immunocompromised patients with proven or probable invasive candidiasis: A retrospective multicentre study. [PDF]

Ann Intensive Care
Jaffal K, Bayon C, Kreitmann L, Rouzé A, Labruyere M, Stoclin A, Reignier J, Brunin G, Dartevel A, Sendid B, Labreuche J, Nseir S.   +11 more
europepmc   +1 more source

A guide to the ecological limitations of phage therapy of bacterial biofilms: Is what's best for the phage best for the physician?

The FEBS Journal, EarlyView.
Bacteriophages—viruses that kill bacteria—are promising weapons against bacterial biofilms: sessile communities notoriously resistant to antibiotics. Yet phages evolved not so much to eradicate bacteria as to obtain new bacteria to infect. That goal, however, may conflict with the physician's objective of complete bacterial clearance.
Stephen T. Abedon
wiley   +1 more source

Development of the Physical Distancing Scale for COVID-19 Avoidance (PDS-C19©) in immunocompromised and non-immunocompromised individuals and its validation in the EAGLE Study. [PDF]

J Patient Rep Outcomes
Marcus JC, Maia T, Williams P, Yokota RTC, Arnetorp S, Herring TA, Venkatesan S, Powell PA, Severens JLH, Varni JW, Taylor S, Krol M, Ware JE.   +12 more
europepmc   +1 more source

In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients

Transplant International
Ilies Benotmane, Ilies Benotmane, Martin Jungbauer-Groznica, Martin Jungbauer-Groznica, Martin Jungbauer-Groznica, Isabelle Staropoli, Delphine Planas, Océane Dehan, Océane Dehan, Angela Brisebarre, Angela Brisebarre, Etienne Simon-Loriere, Etienne Simon-Loriere, Samira Fafi-Kremer, Samira Fafi-Kremer, Olivier Schwartz, Olivier Schwartz, Timothée Bruel, Timothée Bruel, Timothée Bruel, Sophie Caillard, Sophie Caillard   +21 more
doaj   +1 more source

Machine Learning Model for Predicting Postoperative Pain in Cases of Irreversible Pulpitis

International Endodontic Journal, EarlyView.
ABSTRACT Aim Postoperative pain is a frequent clinical concern following endodontic treatment. This study aimed to develop and validate supervised machine learning models to predict the occurrence of postoperative pain in cases of irreversible pulpitis.
Pedro Felipe de Jesus Freitas, Ingrid Luiza Mendonça Cunha, Thalita de Paris Matos, Flares Baratto‐Filho, Bianca Marques de Mattos de Araujo, Manoel Damião Sousa‐Neto, Leandro de Moura Martins, Fernando José Herkrath, Emílio Carlos Sponchiado‐Júnior, Cristiano Miranda de Araujo   +9 more
wiley   +1 more source

From emerging viral pathogens to pan-resistant bacteria: toward a post-antibiotic era in immunocompromised patients. [PDF]

Ann Med Surg (Lond)
Yousaf A, Shahid I, Jaber M.
europepmc   +1 more source

Babesiosis in non-immunocompromised versus immunocompromised patients

, 2017
Cruz, Nicole M., Mehta, Amit, Gupta, Renuka   +2 more
openaire   +1 more source